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ABSTRACT
Platelet Activating Factor Acetyl Hydrolase (PAF AH) or LpPLA2 is a key enzyme in myocardial 
infarction catalyzes the sn-2 acetyl group of Platelet Activating Factor (PAF)  into lyso PAF and acetate 
as non-potent inflammatory molecules. PAF AH plays a critical role in arterial plaque development of 
Coronary Artery Disease (CAD). A crystal structure of PAF AH complexes with other ligand and 
effects of amino acid alteration to protein plasma consequence have also been reported. Here we report 
on the result of molecular docking and Molecular dynamic (MD) simulation carried out for PAF AH 
wild type (WT)/PAF and mutant Q281R/PAF complexes. The docking result shows that amino acid 
residues on active site of Q281 PAF AH mutant have not been recognized on PAF AH. Eelectrostatics 
and hydrophobic bonds significantly reduced in Q281R than in the wild type. The 7500 ps MD simu-
lation Q281R showed less dynamics than WT but enzymatic machinary of mutant Q281R was not 
interrupted during MD simulation as well as PAF AH wildtype. These findings clearly indicated the im-
portant effect of mutant Q281R in PAF AH recognition to its substrate.
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INTRODUCTION
Cardiovascular disease is the largest cause of 
morbidity and mortality in Indonesia according 
to WHO in 2011 [1]. This disease is caused by 
multiple factors including aging, genetic, and 
lifestyle factors. Coronary Heart Disease (CHD) is 
the most common disease in the community [2]. 
CHD events start from endothelial dys-function in 
the arteries due to risk factors such as diabetes 
mellitus, dyslipidemia, smoking, hyper-tension, and 
obesity. Endothelial dysfunction cause low density 
lipoprotein (LDL)-cholesterol to be trapped within 
tunica layer and induce inflmmation facilitated by 
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macrophages. This process induces bulky macro-
phages form, foam cells and fatty streak which 
causes narrowing of the lumen of the coronary 
arteries [3-5].
Protein markers that could indicate the occur-
rence of endothelial dysfunction is Acetyl-hydro
lase Platelet Activating Factor (PAF-AH) [3]. 
PAF AH or LPPLA2 is Ca2+ independent phospo
lipase that degrades platelet activating fac-tor 
(PAF) as a substrate. The interaction of these two 
molecules is a form of inflammatory res-ponse to 
athero sclerosis pathological conditions. PAF-AH 
is a super family of enzymes that cata-lyze fatty 
acid in sn-2 position (nucleotide subs-titutions) 
gliserophospolipid acetyl group into lysophospho
lipids and acetate which are mole-cules that are 
non-potent inflammatory agent. This enzyme is 
45 kDa and is secreted by macro-phages into the 
plasma in the active form [6].
One rare mutation located in adjacent to the 
highly conserve region and also flanked by active 
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site residue, Ser273 and Asp296 is the turn of 
bases A1001G [7]. This mutation is found in 
population of Japanese women with cardiovas-
cular disease and clinical condition of essential 
hypertension. These mutations result in amino 
acid substitutions of Glycine to Arginine number 
281 (Q281R) and also cause loss of enzyme 
catalytic activity of PAF-AH. At the North Ame-
rican population, this mutation is very common 
and  the highest prevalence of mutations causes
partial loss of enzymatic activity of PAF-AH [6-
8]. Since this mutation is located in a prominent 
position and attacked women with essential hy-
pertension and CAD, therefore, this study was 
conducted to explore the effect of Q281R muta-
tion using in-silico approach.
MATERIALS AND METHODS
Protein structure preparation
Three dimensional crystal structure of wild type 
human PAF AH was retrieved from RSCB PDB 
[3D59] comprising 383 amino acid residues [9]. 2D 
structure and Ramachandran plot of mutant 
Q281R was done by using JPRED [10] and 
PROCHECK [11, 12] web server. Homology 
modeling approach was chosen to construct the 
3D structure of Q281R using SWISS MODEL [13, 
14]. The pocket site checking was analyzed by 
CASTpweb server [15]. The structure of PAF as 
ligand was downloaded from PubChem in pdf file 
format.
Docking PAF onto PAF AH
To prepare molecules for docking, all mole-
cules were checked using YASARA to fix all 
atoms. Two hundred times energy minimization 
was applied for PAF molecule using Open Babel in 
Pyrx software. Docking molecule between two 
types of PAF AH and PAF molecules was per-
formed using AutodockVina software with a de-
fault parameter for choosing grid (X:25.000, 
Y:25.000, Z:25000) and the exhaustiveness de-gree 
was eight. To analyze and overview the docking 
result, PyMol and DeepView 4.1.0 were used. 
Interactions between wildtype and mutant of PAF 
AH were checked using Ligandscout [16].
Molecular Dynamics Simulation in Water
Docking results were subjected to molecular 
dynamics simulation which was performed using 
YASARA software, version 13.2.21 with the 
AMBER03 force field. All complex protein 
placed in a box that was 10Ǻ larger than each 
side of the protein [9]. Hydrogen atoms were 
added to counterweigh pH and pKa value, when 
the simulation was applied, the pKa value was
higher than the pH value. Ewald method was 
used in YASARA simulation to compute pKa in 
all molecules used [17]. The complex structures 
were than minimized using steepest-descent 
method and followed by simulated annealing. 
Equalizing to the real cell condition, water sol-
vent, 7.0 pH values in 0.9% NaCl for 300 K tem-
perature for 4000 ps were performed. Intra-
molecular and intermolecular forces were used 
for multiple time steps 1.25 and 2.5 fs. Simu-
lation was done using Intel Core2Quad 2.83 Ghz, 
with 2 GB of RAM.
RESULTS AND DISCUSSION
It is known widely that PAF-AH enzyme plays 
an important role in cardiovascular disease. This 
protein has been used as a marker for myocardial 
infarction [18-20]. Interestingly, these enzymes 
are involved in two different pathways, inflam-
matory and non-inflammatory, depending on the 
substrates, oxLDL or PAF. There is no known 
mechanism accounting for a drift between pro-
and anti-inflammatory functions associated with 
PAF-AH. It is believed that what determines the 
final outcome is dictated by the net change in 
substrates and products, the environment in 
which the enzyme functions, and the type of cell 
that expresses the enzyme. 
PAF-AH hydrolysis of PAF produces two 
molecules that are non-inflammatory, Lyso PAF 
and acetate. However, their interaction has never 
been studied before, although the active site of 
PAF-AH and its interaction with other molecules 
is clearly described [21]. We analyzed interaction 
between PAF-AH and PAF using a molecular 
docking by first obtained a 3D structure through 
homology modeling. The quality and reliability of 
structure was checked using PROCHECK based 
on Ramachandran plot, and most favored region 
and amino acid were 90% for all total residues 
(Figure 1).
3D modeling showed that there were no 
differences for two dimensional structure bet-
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ween mutant (Q281R) and wild type. This result 
might be caused due to the replacement of only
one amino acid to build Q281R mutant.
Figure 1. 3D structure of PAF AH
However, we used FoldX from YASARA to 
check destabilization structure for both struc-
tures. Q281R showed many steric clashes (data 
not shown) and the destabilization value was
higher than the wild type structure, with the value 
of destabilization for Q281R was -0.57 kcal/mol,
much higher than stabilization value of wild type -
85.72 kcal/mol. Destabilization structure occurs 
when there is an increasing number more than 
+0.5 kacal/mol from wild type [22].
To check binding site between PAF AH (wild 
type and mutant) and PAF, we performed rigid 
docking. The affinity energy from this process 
was -4.0 kcal/mol to -2.2 kcal/mol for wild-type 
and mutant structures respectively. This value has 
an important meaning since alteration Glutamine 
to Arginin may disturb binding process and cause
more steric clashes [23, 24]. 
Figure 2. A) Hydrogen and hydrophobic interaction between PAF AH-PAF (above) and PAF position during docking 
process (below). (A) Wild type, (B) Mutant Q281R. B) Cα-atomic movement of overall PAF AH residues. C) Active 
site consisted residues movement.
Using LIGPLUS and LigandScout, all inte-
ractions between PAF AH (wild type and mutant) 
and PAF can be mapped (Figure 2A). Wild type 
docking onto PAF showed three active residues 
(His351, Ser273, Asp296) of PAF AH enzyme 
bound to Phospocholine chain of PAF. Other-
wise, mutant structure showed no active site resi-
due recognized by PAF as ligand. It seemed that 
defect on PAF AH structure abolished active site 
to bind on Phospocholine chain of PAF. Data 
showed earlier explaining that Glutamin alte-
ration to Arginin may causes enzymatic structural 
defect that affects enzyme-substrate binding inte-
raction. However, this data still cannot explain 
how mutation affects enzymatic machinery. Thus,
dynamic simulation was performed to figure out 
this phenomenon. Using water as solvent to 
adapt for its biological circumstances, we found 
A B
C
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that Cα RMS atoms movement during simulation 
for Q281R complex had lower RMSD value that 
the wild type. The Q281R RMSD value was 1.4 Å 
and 1.7 Å for wild type. This value means that 
for all residues of PAF-AH, Q281R is less stable 
compared to the wild type. No active residues of 
catalytic sites reached highest peak (Figure 2B) 
for overall complexes. However, Ser273 residue 
of active site showed higher atomic movement 
compared to Asp296 and 351 (Figure 2C).
CONCLUSIONS
GlutaminArginin 281 alteration of PAF-AH 
enzyme causes serious effect for binding recog-
nition with its substrate, PAF. This approach 
gives new understanding that rare mutation of 
Q281R PAF-AH may cause serious outcome due 
to PAF-AH enzyme activity to have been abo-
lished during PAF- PAF-AH recognition. This 
new finding can be the first evident to make 
Q281R mutation examination for women CAD 
patients, especially in developing country.
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